QPW
EWTX icon

Quantum Private Wealth’s Edgewise Therapeutics EWTX Stock Holding History

Quantum Private Wealth’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.61M Sell
113,380
-3,244
-3% -$112K 1.18% 20
2026
Q1 		$3.67M Buy
116,624
+10,600
+10% +$306K 1.13% 16
2025
Q4 		$2.63M Buy
106,024
+150
+0.1% +$3.01K 0.77% 27
2025
Q3 		$1.72M Buy
105,874
+5,100
+5% +$72.3K 0.5% 41
2025
Q2 		$1.32M Buy
100,774
+10,050
+11% +$145K 0.43% 43
2025
Q1 		$2M Buy
90,724
+17,200
+23% +$451K 0.76% 25
2024
Q4 		$1.96M Buy
73,524
+100
+0.1% +$3.18K 0.63% 34
2024
Q3 		$1.96M Buy
73,424
+6,650
+10% +$132K 0.66% 29
2024
Q2 		$1.2M Buy
66,774
+100
+0.1% +$1.74K 0.43% 47
2024
Q1 		$1.22M Buy
66,674
+3,455
+5% +$54.9K 0.45% 49
2023
Q4 		$692K Buy
63,219
+1,500
+2% +$10.5K 0.29% 79
2023
Q3 		$354K Buy
61,719
+500
+0.8% +$3.4K 0.17% 122
2023
Q2 		$474K Buy
61,219
+12,500
+26% +$105K 0.22% 99
2023
Q1 		$325K Buy
48,719
+11,461
+31% +$106K 0.18% 124
2022
Q4 		$333K Buy
37,258
+3,950
+12% +$37K 0.21% 114
2022
Q3 		$327K Buy
33,308
+10,437
+46% +$105K 0.2% 118
2022
Q2 		$182K Buy
22,871
+629
+3% +$4.75K 0.11% 161
2022
Q1 		$215K Buy
22,242
+2,890
+15% +$37.2K 0.09% 180
2021
Q4 		$295K Buy
+19,352
New +$348K 0.11% 158

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Quantum Private Wealth's EWTX Position: Q2 2026 in Review

Quantum Private Wealth reduced its Edgewise Therapeutics (EWTX) stake by 2.8% in Q2 2026, selling an estimated $112K and leaving 113,380 shares worth $4.61M. The position accounts for 1.18% of the portfolio, ranked #20.

Quantum Private Wealth first reported a position in EWTX in Q4 2021 and has held it in 19 quarters since. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Quantum Private Wealth held 113,380 shares of Edgewise Therapeutics worth $4.61M as of Q2 2026.
  • Quantum Private Wealth sold 3,244 Edgewise Therapeutics shares in Q2 2026, an estimated $112K.
  • Edgewise Therapeutics made up 1.18% of Quantum Private Wealth's portfolio in Q2 2026, its #20 holding.
  • Quantum Private Wealth first reported a position in Edgewise Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Quantum Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.